Global CAR-T Drugs Market Growth (Status and Outlook) 2026-2032
The global CAR-T Drugs market size is predicted to grow from US$ 5381 million in 2025 to US$ 12430 million in 2032; it is expected to grow at a CAGR of 12.9% from 2026 to 2032.
CAR-T (Chimeric antigen receptor T cell) therapy involves the transfer of genetic material containing specific antigen recognition domains and T cell activation signals into T cells through gene modification technology. This allows T cells to directly bind to specific antigens on the surface of tumor cells and become activated. They then release perforin, granzyme B, and other proteins to directly kill tumor cells. Simultaneously, cytokine release recruits endogenous immune cells to kill tumor cells, thereby achieving the goal of treating tumors. Furthermore, CAR-T therapy can form immune memory T cells, resulting in a specific, long-lasting anti-tumor mechanism.
In the CAR-T therapy industry chain, upstream manufacturers of equipment such as flow cytometers are responsible for supplying reagents for T cell sorting and transfection, as well as raw materials and excipients such as cytokines. Midstream and downstream players, respectively, engage in CAR-T therapy R&D and product production.
Global cancer prevalence continues to rise. This increase in the number of cancer patients will drive the global cancer treatment market, including the global CAR-T therapy market.
With the continuous optimization of treatment protocols and manufacturing processes, the toxicity issues associated with CAR-T therapy will be alleviated and safety will be improved. This is expected to attract more patients to CAR-T cell therapy and further expand its market size. Currently, the manufacturing process for CAR-T cell therapy is complex, costly, and inefficient. As manufacturing technology and processes mature, production efficiency will be further improved. Furthermore, the use of lower-cost automated systems will better ensure batch-to-batch consistency of cell products.
Due to the high cost of treatment, CAR-T cell therapy often imposes a heavy financial burden on patients. To increase accessibility, European and American countries have gradually developed a diversified payment system combining commercial insurance and medical insurance, which offers valuable insights for other countries.
LPI (LP Information)' newest research report, the “CAR-T Drugs Industry Forecast” looks at past sales and reviews total world CAR-T Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-T Drugs sales for 2026 through 2032. With CAR-T Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Drugs industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-T Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-T Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
CAR-T (Chimeric antigen receptor T cell) therapy involves the transfer of genetic material containing specific antigen recognition domains and T cell activation signals into T cells through gene modification technology. This allows T cells to directly bind to specific antigens on the surface of tumor cells and become activated. They then release perforin, granzyme B, and other proteins to directly kill tumor cells. Simultaneously, cytokine release recruits endogenous immune cells to kill tumor cells, thereby achieving the goal of treating tumors. Furthermore, CAR-T therapy can form immune memory T cells, resulting in a specific, long-lasting anti-tumor mechanism.
In the CAR-T therapy industry chain, upstream manufacturers of equipment such as flow cytometers are responsible for supplying reagents for T cell sorting and transfection, as well as raw materials and excipients such as cytokines. Midstream and downstream players, respectively, engage in CAR-T therapy R&D and product production.
Global cancer prevalence continues to rise. This increase in the number of cancer patients will drive the global cancer treatment market, including the global CAR-T therapy market.
With the continuous optimization of treatment protocols and manufacturing processes, the toxicity issues associated with CAR-T therapy will be alleviated and safety will be improved. This is expected to attract more patients to CAR-T cell therapy and further expand its market size. Currently, the manufacturing process for CAR-T cell therapy is complex, costly, and inefficient. As manufacturing technology and processes mature, production efficiency will be further improved. Furthermore, the use of lower-cost automated systems will better ensure batch-to-batch consistency of cell products.
Due to the high cost of treatment, CAR-T cell therapy often imposes a heavy financial burden on patients. To increase accessibility, European and American countries have gradually developed a diversified payment system combining commercial insurance and medical insurance, which offers valuable insights for other countries.
LPI (LP Information)' newest research report, the “CAR-T Drugs Industry Forecast” looks at past sales and reviews total world CAR-T Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected CAR-T Drugs sales for 2026 through 2032. With CAR-T Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CAR-T Drugs industry.
This Insight Report provides a comprehensive analysis of the global CAR-T Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CAR-T Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CAR-T Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CAR-T Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CAR-T Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR-T Drugs market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Single Target
- Multiple Targets
- Autologous
- Allogeneic
- First Generation
- Second Generation
- Third Generation
- Fourth Generation
- Hematoma
- Solid Tumors
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead Sciences
- Novartis
- Bristol Myers Squibb
- Johnson & Johnson (Legend Biotech)
- Fosun Kairos
- ISAO Bio
- JW (Cayman) Therapeutics
- CARsgen Therapeutics
- Juventas Cell Therapy
- Hrain Biotechnology Co
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-T Drugs Market Size (2021-2032)
2.1.2 CAR-T Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR-T Drugs by Country/Region (2021, 2025 & 2032)
2.2 CAR-T Drugs Segment by Type
2.2.1 Single Target
2.2.2 Multiple Targets
2.2.3 CAR-T Drugs Market Size by Type
2.2.3.1 CAR-T Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global CAR-T Drugs Market Size Market Share by Type (2021-2026)
2.3 CAR-T Drugs Segment by Source
2.3.1 Autologous
2.3.2 Allogeneic
2.3.3 CAR-T Drugs Market Size by Source
2.3.3.1 CAR-T Drugs Market Size CAGR by Source (2021 VS 2025 VS 2032)
2.3.3.2 Global CAR-T Drugs Market Size Market Share by Source (2021-2026)
2.4 CAR-T Drugs Segment by Generation
2.4.1 First Generation
2.4.2 Second Generation
2.4.3 Third Generation
2.4.4 Fourth Generation
2.4.5 CAR-T Drugs Market Size by Generation
2.4.5.1 CAR-T Drugs Market Size CAGR by Generation (2021 VS 2025 VS 2032)
2.4.5.2 Global CAR-T Drugs Market Size Market Share by Generation (2021-2026)
2.5 CAR-T Drugs Segment by Application
2.5.1 Hematoma
2.5.2 Solid Tumors
2.5.3 Others
2.5.4 CAR-T Drugs Market Size by Application
2.5.4.1 CAR-T Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global CAR-T Drugs Market Size Market Share by Application (2021-2026)
3 CAR-T DRUGS MARKET SIZE BY PLAYER
3.1 CAR-T Drugs Market Size Market Share by Player
3.1.1 Global CAR-T Drugs Revenue by Player (2021-2026)
3.1.2 Global CAR-T Drugs Revenue Market Share by Player (2021-2026)
3.2 Global CAR-T Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T DRUGS BY REGION
4.1 CAR-T Drugs Market Size by Region (2021-2026)
4.2 Global CAR-T Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-T Drugs Market Size Growth (2021-2026)
4.4 APAC CAR-T Drugs Market Size Growth (2021-2026)
4.5 Europe CAR-T Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR-T Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR-T Drugs Market Size by Country (2021-2026)
5.2 Americas CAR-T Drugs Market Size by Type (2021-2026)
5.3 Americas CAR-T Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Drugs Market Size by Region (2021-2026)
6.2 APAC CAR-T Drugs Market Size by Type (2021-2026)
6.3 APAC CAR-T Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR-T Drugs Market Size by Country (2021-2026)
7.2 Europe CAR-T Drugs Market Size by Type (2021-2026)
7.3 Europe CAR-T Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-T Drugs by Region (2021-2026)
8.2 Middle East & Africa CAR-T Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa CAR-T Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR-T DRUGS MARKET FORECAST
10.1 Global CAR-T Drugs Forecast by Region (2027-2032)
10.1.1 Global CAR-T Drugs Forecast by Region (2027-2032)
10.1.2 Americas CAR-T Drugs Forecast
10.1.3 APAC CAR-T Drugs Forecast
10.1.4 Europe CAR-T Drugs Forecast
10.1.5 Middle East & Africa CAR-T Drugs Forecast
10.2 Americas CAR-T Drugs Forecast by Country (2027-2032)
10.2.1 United States Market CAR-T Drugs Forecast
10.2.2 Canada Market CAR-T Drugs Forecast
10.2.3 Mexico Market CAR-T Drugs Forecast
10.2.4 Brazil Market CAR-T Drugs Forecast
10.3 APAC CAR-T Drugs Forecast by Region (2027-2032)
10.3.1 China CAR-T Drugs Market Forecast
10.3.2 Japan Market CAR-T Drugs Forecast
10.3.3 Korea Market CAR-T Drugs Forecast
10.3.4 Southeast Asia Market CAR-T Drugs Forecast
10.3.5 India Market CAR-T Drugs Forecast
10.3.6 Australia Market CAR-T Drugs Forecast
10.4 Europe CAR-T Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market CAR-T Drugs Forecast
10.4.2 France Market CAR-T Drugs Forecast
10.4.3 UK Market CAR-T Drugs Forecast
10.4.4 Italy Market CAR-T Drugs Forecast
10.4.5 Russia Market CAR-T Drugs Forecast
10.5 Middle East & Africa CAR-T Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR-T Drugs Forecast
10.5.2 South Africa Market CAR-T Drugs Forecast
10.5.3 Israel Market CAR-T Drugs Forecast
10.5.4 Turkey Market CAR-T Drugs Forecast
10.6 Global CAR-T Drugs Forecast by Type (2027-2032)
10.7 Global CAR-T Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR-T Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Information
11.1.2 Gilead Sciences CAR-T Drugs Product Offered
11.1.3 Gilead Sciences CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Gilead Sciences Main Business Overview
11.1.5 Gilead Sciences Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis CAR-T Drugs Product Offered
11.2.3 Novartis CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Information
11.3.2 Bristol Myers Squibb CAR-T Drugs Product Offered
11.3.3 Bristol Myers Squibb CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol Myers Squibb Main Business Overview
11.3.5 Bristol Myers Squibb Latest Developments
11.4 Johnson & Johnson (Legend Biotech)
11.4.1 Johnson & Johnson (Legend Biotech) Company Information
11.4.2 Johnson & Johnson (Legend Biotech) CAR-T Drugs Product Offered
11.4.3 Johnson & Johnson (Legend Biotech) CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Johnson & Johnson (Legend Biotech) Main Business Overview
11.4.5 Johnson & Johnson (Legend Biotech) Latest Developments
11.5 Fosun Kairos
11.5.1 Fosun Kairos Company Information
11.5.2 Fosun Kairos CAR-T Drugs Product Offered
11.5.3 Fosun Kairos CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fosun Kairos Main Business Overview
11.5.5 Fosun Kairos Latest Developments
11.6 ISAO Bio
11.6.1 ISAO Bio Company Information
11.6.2 ISAO Bio CAR-T Drugs Product Offered
11.6.3 ISAO Bio CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 ISAO Bio Main Business Overview
11.6.5 ISAO Bio Latest Developments
11.7 JW (Cayman) Therapeutics
11.7.1 JW (Cayman) Therapeutics Company Information
11.7.2 JW (Cayman) Therapeutics CAR-T Drugs Product Offered
11.7.3 JW (Cayman) Therapeutics CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 JW (Cayman) Therapeutics Main Business Overview
11.7.5 JW (Cayman) Therapeutics Latest Developments
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Information
11.8.2 CARsgen Therapeutics CAR-T Drugs Product Offered
11.8.3 CARsgen Therapeutics CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 CARsgen Therapeutics Main Business Overview
11.8.5 CARsgen Therapeutics Latest Developments
11.9 Juventas Cell Therapy
11.9.1 Juventas Cell Therapy Company Information
11.9.2 Juventas Cell Therapy CAR-T Drugs Product Offered
11.9.3 Juventas Cell Therapy CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Juventas Cell Therapy Main Business Overview
11.9.5 Juventas Cell Therapy Latest Developments
11.10 Hrain Biotechnology Co
11.10.1 Hrain Biotechnology Co Company Information
11.10.2 Hrain Biotechnology Co CAR-T Drugs Product Offered
11.10.3 Hrain Biotechnology Co CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Hrain Biotechnology Co Main Business Overview
11.10.5 Hrain Biotechnology Co Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CAR-T Drugs Market Size (2021-2032)
2.1.2 CAR-T Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for CAR-T Drugs by Country/Region (2021, 2025 & 2032)
2.2 CAR-T Drugs Segment by Type
2.2.1 Single Target
2.2.2 Multiple Targets
2.2.3 CAR-T Drugs Market Size by Type
2.2.3.1 CAR-T Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global CAR-T Drugs Market Size Market Share by Type (2021-2026)
2.3 CAR-T Drugs Segment by Source
2.3.1 Autologous
2.3.2 Allogeneic
2.3.3 CAR-T Drugs Market Size by Source
2.3.3.1 CAR-T Drugs Market Size CAGR by Source (2021 VS 2025 VS 2032)
2.3.3.2 Global CAR-T Drugs Market Size Market Share by Source (2021-2026)
2.4 CAR-T Drugs Segment by Generation
2.4.1 First Generation
2.4.2 Second Generation
2.4.3 Third Generation
2.4.4 Fourth Generation
2.4.5 CAR-T Drugs Market Size by Generation
2.4.5.1 CAR-T Drugs Market Size CAGR by Generation (2021 VS 2025 VS 2032)
2.4.5.2 Global CAR-T Drugs Market Size Market Share by Generation (2021-2026)
2.5 CAR-T Drugs Segment by Application
2.5.1 Hematoma
2.5.2 Solid Tumors
2.5.3 Others
2.5.4 CAR-T Drugs Market Size by Application
2.5.4.1 CAR-T Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.4.2 Global CAR-T Drugs Market Size Market Share by Application (2021-2026)
3 CAR-T DRUGS MARKET SIZE BY PLAYER
3.1 CAR-T Drugs Market Size Market Share by Player
3.1.1 Global CAR-T Drugs Revenue by Player (2021-2026)
3.1.2 Global CAR-T Drugs Revenue Market Share by Player (2021-2026)
3.2 Global CAR-T Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR-T DRUGS BY REGION
4.1 CAR-T Drugs Market Size by Region (2021-2026)
4.2 Global CAR-T Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas CAR-T Drugs Market Size Growth (2021-2026)
4.4 APAC CAR-T Drugs Market Size Growth (2021-2026)
4.5 Europe CAR-T Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa CAR-T Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas CAR-T Drugs Market Size by Country (2021-2026)
5.2 Americas CAR-T Drugs Market Size by Type (2021-2026)
5.3 Americas CAR-T Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR-T Drugs Market Size by Region (2021-2026)
6.2 APAC CAR-T Drugs Market Size by Type (2021-2026)
6.3 APAC CAR-T Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CAR-T Drugs Market Size by Country (2021-2026)
7.2 Europe CAR-T Drugs Market Size by Type (2021-2026)
7.3 Europe CAR-T Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CAR-T Drugs by Region (2021-2026)
8.2 Middle East & Africa CAR-T Drugs Market Size by Type (2021-2026)
8.3 Middle East & Africa CAR-T Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CAR-T DRUGS MARKET FORECAST
10.1 Global CAR-T Drugs Forecast by Region (2027-2032)
10.1.1 Global CAR-T Drugs Forecast by Region (2027-2032)
10.1.2 Americas CAR-T Drugs Forecast
10.1.3 APAC CAR-T Drugs Forecast
10.1.4 Europe CAR-T Drugs Forecast
10.1.5 Middle East & Africa CAR-T Drugs Forecast
10.2 Americas CAR-T Drugs Forecast by Country (2027-2032)
10.2.1 United States Market CAR-T Drugs Forecast
10.2.2 Canada Market CAR-T Drugs Forecast
10.2.3 Mexico Market CAR-T Drugs Forecast
10.2.4 Brazil Market CAR-T Drugs Forecast
10.3 APAC CAR-T Drugs Forecast by Region (2027-2032)
10.3.1 China CAR-T Drugs Market Forecast
10.3.2 Japan Market CAR-T Drugs Forecast
10.3.3 Korea Market CAR-T Drugs Forecast
10.3.4 Southeast Asia Market CAR-T Drugs Forecast
10.3.5 India Market CAR-T Drugs Forecast
10.3.6 Australia Market CAR-T Drugs Forecast
10.4 Europe CAR-T Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market CAR-T Drugs Forecast
10.4.2 France Market CAR-T Drugs Forecast
10.4.3 UK Market CAR-T Drugs Forecast
10.4.4 Italy Market CAR-T Drugs Forecast
10.4.5 Russia Market CAR-T Drugs Forecast
10.5 Middle East & Africa CAR-T Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market CAR-T Drugs Forecast
10.5.2 South Africa Market CAR-T Drugs Forecast
10.5.3 Israel Market CAR-T Drugs Forecast
10.5.4 Turkey Market CAR-T Drugs Forecast
10.6 Global CAR-T Drugs Forecast by Type (2027-2032)
10.7 Global CAR-T Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market CAR-T Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Gilead Sciences
11.1.1 Gilead Sciences Company Information
11.1.2 Gilead Sciences CAR-T Drugs Product Offered
11.1.3 Gilead Sciences CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Gilead Sciences Main Business Overview
11.1.5 Gilead Sciences Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis CAR-T Drugs Product Offered
11.2.3 Novartis CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Information
11.3.2 Bristol Myers Squibb CAR-T Drugs Product Offered
11.3.3 Bristol Myers Squibb CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Bristol Myers Squibb Main Business Overview
11.3.5 Bristol Myers Squibb Latest Developments
11.4 Johnson & Johnson (Legend Biotech)
11.4.1 Johnson & Johnson (Legend Biotech) Company Information
11.4.2 Johnson & Johnson (Legend Biotech) CAR-T Drugs Product Offered
11.4.3 Johnson & Johnson (Legend Biotech) CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Johnson & Johnson (Legend Biotech) Main Business Overview
11.4.5 Johnson & Johnson (Legend Biotech) Latest Developments
11.5 Fosun Kairos
11.5.1 Fosun Kairos Company Information
11.5.2 Fosun Kairos CAR-T Drugs Product Offered
11.5.3 Fosun Kairos CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Fosun Kairos Main Business Overview
11.5.5 Fosun Kairos Latest Developments
11.6 ISAO Bio
11.6.1 ISAO Bio Company Information
11.6.2 ISAO Bio CAR-T Drugs Product Offered
11.6.3 ISAO Bio CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 ISAO Bio Main Business Overview
11.6.5 ISAO Bio Latest Developments
11.7 JW (Cayman) Therapeutics
11.7.1 JW (Cayman) Therapeutics Company Information
11.7.2 JW (Cayman) Therapeutics CAR-T Drugs Product Offered
11.7.3 JW (Cayman) Therapeutics CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 JW (Cayman) Therapeutics Main Business Overview
11.7.5 JW (Cayman) Therapeutics Latest Developments
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Information
11.8.2 CARsgen Therapeutics CAR-T Drugs Product Offered
11.8.3 CARsgen Therapeutics CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 CARsgen Therapeutics Main Business Overview
11.8.5 CARsgen Therapeutics Latest Developments
11.9 Juventas Cell Therapy
11.9.1 Juventas Cell Therapy Company Information
11.9.2 Juventas Cell Therapy CAR-T Drugs Product Offered
11.9.3 Juventas Cell Therapy CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Juventas Cell Therapy Main Business Overview
11.9.5 Juventas Cell Therapy Latest Developments
11.10 Hrain Biotechnology Co
11.10.1 Hrain Biotechnology Co Company Information
11.10.2 Hrain Biotechnology Co CAR-T Drugs Product Offered
11.10.3 Hrain Biotechnology Co CAR-T Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Hrain Biotechnology Co Main Business Overview
11.10.5 Hrain Biotechnology Co Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. CAR-T Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR-T Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Target
Table 4. Major Players of Multiple Targets
Table 5. CAR-T Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 7. Global CAR-T Drugs Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Autologous
Table 9. Major Players of Allogeneic
Table 10. CAR-T Drugs Market Size CAGR by Source (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global CAR-T Drugs Market Size by Source (2021-2026) & ($ millions)
Table 12. Global CAR-T Drugs Market Size Market Share by Source (2021-2026)
Table 13. Major Players of First Generation
Table 14. Major Players of Second Generation
Table 15. Major Players of Third Generation
Table 16. Major Players of Fourth Generation
Table 17. CAR-T Drugs Market Size CAGR by Generation (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global CAR-T Drugs Market Size by Generation (2021-2026) & ($ millions)
Table 19. Global CAR-T Drugs Market Size Market Share by Generation (2021-2026)
Table 20. CAR-T Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 22. Global CAR-T Drugs Market Size Market Share by Application (2021-2026)
Table 23. Global CAR-T Drugs Revenue by Player (2021-2026) & ($ millions)
Table 24. Global CAR-T Drugs Revenue Market Share by Player (2021-2026)
Table 25. CAR-T Drugs Key Players Head office and Products Offered
Table 26. CAR-T Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global CAR-T Drugs Market Size by Region (2021-2026) & ($ millions)
Table 30. Global CAR-T Drugs Market Size Market Share by Region (2021-2026)
Table 31. Global CAR-T Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global CAR-T Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas CAR-T Drugs Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas CAR-T Drugs Market Size Market Share by Country (2021-2026)
Table 35. Americas CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas CAR-T Drugs Market Size Market Share by Type (2021-2026)
Table 37. Americas CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas CAR-T Drugs Market Size Market Share by Application (2021-2026)
Table 39. APAC CAR-T Drugs Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC CAR-T Drugs Market Size Market Share by Region (2021-2026)
Table 41. APAC CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe CAR-T Drugs Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe CAR-T Drugs Market Size Market Share by Country (2021-2026)
Table 45. Europe CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa CAR-T Drugs Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of CAR-T Drugs
Table 51. Key Market Challenges & Risks of CAR-T Drugs
Table 52. Key Industry Trends of CAR-T Drugs
Table 53. Global CAR-T Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global CAR-T Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global CAR-T Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global CAR-T Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Gilead Sciences Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 58. Gilead Sciences CAR-T Drugs Product Offered
Table 59. Gilead Sciences CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Gilead Sciences Main Business
Table 61. Gilead Sciences Latest Developments
Table 62. Novartis Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 63. Novartis CAR-T Drugs Product Offered
Table 64. Novartis CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Novartis Main Business
Table 66. Novartis Latest Developments
Table 67. Bristol Myers Squibb Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 68. Bristol Myers Squibb CAR-T Drugs Product Offered
Table 69. Bristol Myers Squibb CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Bristol Myers Squibb Main Business
Table 71. Bristol Myers Squibb Latest Developments
Table 72. Johnson & Johnson (Legend Biotech) Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 73. Johnson & Johnson (Legend Biotech) CAR-T Drugs Product Offered
Table 74. Johnson & Johnson (Legend Biotech) CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Johnson & Johnson (Legend Biotech) Main Business
Table 76. Johnson & Johnson (Legend Biotech) Latest Developments
Table 77. Fosun Kairos Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 78. Fosun Kairos CAR-T Drugs Product Offered
Table 79. Fosun Kairos CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Fosun Kairos Main Business
Table 81. Fosun Kairos Latest Developments
Table 82. ISAO Bio Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 83. ISAO Bio CAR-T Drugs Product Offered
Table 84. ISAO Bio CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. ISAO Bio Main Business
Table 86. ISAO Bio Latest Developments
Table 87. JW (Cayman) Therapeutics Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 88. JW (Cayman) Therapeutics CAR-T Drugs Product Offered
Table 89. JW (Cayman) Therapeutics CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. JW (Cayman) Therapeutics Main Business
Table 91. JW (Cayman) Therapeutics Latest Developments
Table 92. CARsgen Therapeutics Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 93. CARsgen Therapeutics CAR-T Drugs Product Offered
Table 94. CARsgen Therapeutics CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. CARsgen Therapeutics Main Business
Table 96. CARsgen Therapeutics Latest Developments
Table 97. Juventas Cell Therapy Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 98. Juventas Cell Therapy CAR-T Drugs Product Offered
Table 99. Juventas Cell Therapy CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Juventas Cell Therapy Main Business
Table 101. Juventas Cell Therapy Latest Developments
Table 102. Hrain Biotechnology Co Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 103. Hrain Biotechnology Co CAR-T Drugs Product Offered
Table 104. Hrain Biotechnology Co CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Hrain Biotechnology Co Main Business
Table 106. Hrain Biotechnology Co Latest Developments
Table 1. CAR-T Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. CAR-T Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Single Target
Table 4. Major Players of Multiple Targets
Table 5. CAR-T Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 7. Global CAR-T Drugs Market Size Market Share by Type (2021-2026)
Table 8. Major Players of Autologous
Table 9. Major Players of Allogeneic
Table 10. CAR-T Drugs Market Size CAGR by Source (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global CAR-T Drugs Market Size by Source (2021-2026) & ($ millions)
Table 12. Global CAR-T Drugs Market Size Market Share by Source (2021-2026)
Table 13. Major Players of First Generation
Table 14. Major Players of Second Generation
Table 15. Major Players of Third Generation
Table 16. Major Players of Fourth Generation
Table 17. CAR-T Drugs Market Size CAGR by Generation (2021 VS 2025 VS 2032) & ($ millions)
Table 18. Global CAR-T Drugs Market Size by Generation (2021-2026) & ($ millions)
Table 19. Global CAR-T Drugs Market Size Market Share by Generation (2021-2026)
Table 20. CAR-T Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 22. Global CAR-T Drugs Market Size Market Share by Application (2021-2026)
Table 23. Global CAR-T Drugs Revenue by Player (2021-2026) & ($ millions)
Table 24. Global CAR-T Drugs Revenue Market Share by Player (2021-2026)
Table 25. CAR-T Drugs Key Players Head office and Products Offered
Table 26. CAR-T Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global CAR-T Drugs Market Size by Region (2021-2026) & ($ millions)
Table 30. Global CAR-T Drugs Market Size Market Share by Region (2021-2026)
Table 31. Global CAR-T Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global CAR-T Drugs Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas CAR-T Drugs Market Size by Country (2021-2026) & ($ millions)
Table 34. Americas CAR-T Drugs Market Size Market Share by Country (2021-2026)
Table 35. Americas CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 36. Americas CAR-T Drugs Market Size Market Share by Type (2021-2026)
Table 37. Americas CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 38. Americas CAR-T Drugs Market Size Market Share by Application (2021-2026)
Table 39. APAC CAR-T Drugs Market Size by Region (2021-2026) & ($ millions)
Table 40. APAC CAR-T Drugs Market Size Market Share by Region (2021-2026)
Table 41. APAC CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 42. APAC CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 43. Europe CAR-T Drugs Market Size by Country (2021-2026) & ($ millions)
Table 44. Europe CAR-T Drugs Market Size Market Share by Country (2021-2026)
Table 45. Europe CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 46. Europe CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 47. Middle East & Africa CAR-T Drugs Market Size by Region (2021-2026) & ($ millions)
Table 48. Middle East & Africa CAR-T Drugs Market Size by Type (2021-2026) & ($ millions)
Table 49. Middle East & Africa CAR-T Drugs Market Size by Application (2021-2026) & ($ millions)
Table 50. Key Market Drivers & Growth Opportunities of CAR-T Drugs
Table 51. Key Market Challenges & Risks of CAR-T Drugs
Table 52. Key Industry Trends of CAR-T Drugs
Table 53. Global CAR-T Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 54. Global CAR-T Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 55. Global CAR-T Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 56. Global CAR-T Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 57. Gilead Sciences Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 58. Gilead Sciences CAR-T Drugs Product Offered
Table 59. Gilead Sciences CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. Gilead Sciences Main Business
Table 61. Gilead Sciences Latest Developments
Table 62. Novartis Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 63. Novartis CAR-T Drugs Product Offered
Table 64. Novartis CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Novartis Main Business
Table 66. Novartis Latest Developments
Table 67. Bristol Myers Squibb Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 68. Bristol Myers Squibb CAR-T Drugs Product Offered
Table 69. Bristol Myers Squibb CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Bristol Myers Squibb Main Business
Table 71. Bristol Myers Squibb Latest Developments
Table 72. Johnson & Johnson (Legend Biotech) Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 73. Johnson & Johnson (Legend Biotech) CAR-T Drugs Product Offered
Table 74. Johnson & Johnson (Legend Biotech) CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. Johnson & Johnson (Legend Biotech) Main Business
Table 76. Johnson & Johnson (Legend Biotech) Latest Developments
Table 77. Fosun Kairos Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 78. Fosun Kairos CAR-T Drugs Product Offered
Table 79. Fosun Kairos CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Fosun Kairos Main Business
Table 81. Fosun Kairos Latest Developments
Table 82. ISAO Bio Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 83. ISAO Bio CAR-T Drugs Product Offered
Table 84. ISAO Bio CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. ISAO Bio Main Business
Table 86. ISAO Bio Latest Developments
Table 87. JW (Cayman) Therapeutics Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 88. JW (Cayman) Therapeutics CAR-T Drugs Product Offered
Table 89. JW (Cayman) Therapeutics CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. JW (Cayman) Therapeutics Main Business
Table 91. JW (Cayman) Therapeutics Latest Developments
Table 92. CARsgen Therapeutics Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 93. CARsgen Therapeutics CAR-T Drugs Product Offered
Table 94. CARsgen Therapeutics CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. CARsgen Therapeutics Main Business
Table 96. CARsgen Therapeutics Latest Developments
Table 97. Juventas Cell Therapy Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 98. Juventas Cell Therapy CAR-T Drugs Product Offered
Table 99. Juventas Cell Therapy CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Juventas Cell Therapy Main Business
Table 101. Juventas Cell Therapy Latest Developments
Table 102. Hrain Biotechnology Co Details, Company Type, CAR-T Drugs Area Served and Its Competitors
Table 103. Hrain Biotechnology Co CAR-T Drugs Product Offered
Table 104. Hrain Biotechnology Co CAR-T Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Hrain Biotechnology Co Main Business
Table 106. Hrain Biotechnology Co Latest Developments
LIST OF FIGURES
Figure 1. CAR-T Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR-T Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR-T Drugs Sales Market Share by Country/Region (2025)
Figure 8. CAR-T Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR-T Drugs Market Size Market Share by Type in 2025
Figure 10. Global CAR-T Drugs Market Size Market Share by Source in 2025
Figure 11. Global CAR-T Drugs Market Size Market Share by Generation in 2025
Figure 12. CAR-T Drugs in Hematoma
Figure 13. Global CAR-T Drugs Market: Hematoma (2021-2026) & ($ millions)
Figure 14. CAR-T Drugs in Solid Tumors
Figure 15. Global CAR-T Drugs Market: Solid Tumors (2021-2026) & ($ millions)
Figure 16. CAR-T Drugs in Others
Figure 17. Global CAR-T Drugs Market: Others (2021-2026) & ($ millions)
Figure 18. Global CAR-T Drugs Market Size Market Share by Application in 2025
Figure 19. Global CAR-T Drugs Revenue Market Share by Player in 2025
Figure 20. Global CAR-T Drugs Market Size Market Share by Region (2021-2026)
Figure 21. Americas CAR-T Drugs Market Size 2021-2026 ($ millions)
Figure 22. APAC CAR-T Drugs Market Size 2021-2026 ($ millions)
Figure 23. Europe CAR-T Drugs Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa CAR-T Drugs Market Size 2021-2026 ($ millions)
Figure 25. Americas CAR-T Drugs Value Market Share by Country in 2025
Figure 26. United States CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC CAR-T Drugs Market Size Market Share by Region in 2025
Figure 31. APAC CAR-T Drugs Market Size Market Share by Type (2021-2026)
Figure 32. APAC CAR-T Drugs Market Size Market Share by Application (2021-2026)
Figure 33. China CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. India CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe CAR-T Drugs Market Size Market Share by Country in 2025
Figure 40. Europe CAR-T Drugs Market Size Market Share by Type (2021-2026)
Figure 41. Europe CAR-T Drugs Market Size Market Share by Application (2021-2026)
Figure 42. Germany CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. France CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. UK CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa CAR-T Drugs Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa CAR-T Drugs Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa CAR-T Drugs Market Size Market Share by Application (2021-2026)
Figure 50. Egypt CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 56. APAC CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 57. Europe CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 59. United States CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 60. Canada CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 61. Mexico CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 62. Brazil CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 63. China CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 64. Japan CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 65. Korea CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 67. India CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 68. Australia CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 69. Germany CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 70. France CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 71. UK CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 72. Italy CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 73. Russia CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 74. Egypt CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 75. South Africa CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 76. Israel CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 77. Turkey CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 78. Global CAR-T Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global CAR-T Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 1. CAR-T Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR-T Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. CAR-T Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. CAR-T Drugs Sales Market Share by Country/Region (2025)
Figure 8. CAR-T Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global CAR-T Drugs Market Size Market Share by Type in 2025
Figure 10. Global CAR-T Drugs Market Size Market Share by Source in 2025
Figure 11. Global CAR-T Drugs Market Size Market Share by Generation in 2025
Figure 12. CAR-T Drugs in Hematoma
Figure 13. Global CAR-T Drugs Market: Hematoma (2021-2026) & ($ millions)
Figure 14. CAR-T Drugs in Solid Tumors
Figure 15. Global CAR-T Drugs Market: Solid Tumors (2021-2026) & ($ millions)
Figure 16. CAR-T Drugs in Others
Figure 17. Global CAR-T Drugs Market: Others (2021-2026) & ($ millions)
Figure 18. Global CAR-T Drugs Market Size Market Share by Application in 2025
Figure 19. Global CAR-T Drugs Revenue Market Share by Player in 2025
Figure 20. Global CAR-T Drugs Market Size Market Share by Region (2021-2026)
Figure 21. Americas CAR-T Drugs Market Size 2021-2026 ($ millions)
Figure 22. APAC CAR-T Drugs Market Size 2021-2026 ($ millions)
Figure 23. Europe CAR-T Drugs Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa CAR-T Drugs Market Size 2021-2026 ($ millions)
Figure 25. Americas CAR-T Drugs Value Market Share by Country in 2025
Figure 26. United States CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC CAR-T Drugs Market Size Market Share by Region in 2025
Figure 31. APAC CAR-T Drugs Market Size Market Share by Type (2021-2026)
Figure 32. APAC CAR-T Drugs Market Size Market Share by Application (2021-2026)
Figure 33. China CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. India CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe CAR-T Drugs Market Size Market Share by Country in 2025
Figure 40. Europe CAR-T Drugs Market Size Market Share by Type (2021-2026)
Figure 41. Europe CAR-T Drugs Market Size Market Share by Application (2021-2026)
Figure 42. Germany CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. France CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. UK CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa CAR-T Drugs Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa CAR-T Drugs Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa CAR-T Drugs Market Size Market Share by Application (2021-2026)
Figure 50. Egypt CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries CAR-T Drugs Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 56. APAC CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 57. Europe CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 59. United States CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 60. Canada CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 61. Mexico CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 62. Brazil CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 63. China CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 64. Japan CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 65. Korea CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 67. India CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 68. Australia CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 69. Germany CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 70. France CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 71. UK CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 72. Italy CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 73. Russia CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 74. Egypt CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 75. South Africa CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 76. Israel CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 77. Turkey CAR-T Drugs Market Size 2027-2032 ($ millions)
Figure 78. Global CAR-T Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global CAR-T Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries CAR-T Drugs Market Size 2027-2032 ($ millions)
